Table 4.

Change in anthropometric measures from baseline to 6 months among a cohort of 70 Hispanic breast cancer survivors participating in a randomized, controlled dietary intervention trial

	Baseline			6 months
	n	Adjusted Mean (SE)a	Adjusted P-valueb	n	Adjusted Mean (SE)a	Change from baseline		Percent change from baseline
						Adjusted Mean (SE)a,c	Adjusted P-valueb	Adjusted Mean (SE)a,c	Adjusted P-valueb
Weight (kg)			0.25				0.22		0.22
Intervention	32	74 (2.7)		28	74.3 (3.7)	−2.2 (2.6)		−2.5% (3.6)
Control	35	78.4 (2.6)		27	81.3 (3.8)	2.3 (2.6)		3.8% (3.6)
BMI (kg/m2)			0.45				0.19		0.20
Intervention	30	30.1 (1)		27	29.1 (1.5)	−1.1 (1.2)		−3.1% (3.8)
Control	35	31.1 (0.9)		26	33.2 (1.4)	1 (1.1)		3.8 % (3.7)
Waist circumference (cm)			0.18				0.05		0.06
Intervention	31	93.1 (2.4)		25	94.9 (2.6)	−1.6 (1.2)		−1.3% (1.2)
Control	34	97.5 (2.3)		25	98.8 (2.6)	1.7 (1.2)		2.1% (1.2)
Hip circumference (cm)			0.09				0.72		0.91
Intervention	31	106.6 (2.5)		25	109.2 (2.8)	−0.3 (1.9)		−0.2% (1.3)
Control	34	112.5 (2.4)		25	112.4 (2.8)	−1.2 (1.9)		−0.4% (1.3)
Waist/hip ratio			0.92				0.22		0.19
Intervention	31	0.9 (0.0)		25	0.9 (0.0)	0.0 (0.0)		−0.9% (2.3)
Control	34	0.9 (0.0)		25	0.9 (0.0)	0.0 (0.0)		3.4% (2.3)

^aEstimated marginal means adjusted for menopausal status and hormone replacement therapy use.

^bP-values calculated from linear regression models for the mean change from baseline comparing intervention and control groups, adjusted for menopausal status and hormone replacement therapy use.

^cThe changes from baseline to 3 and 6 months do not match the difference of the adjusted means for two reasons: 1) in some of the comparisons there are differences in the number of participants included, and 2) the regression model used to assess the differences between groups uses a calculated difference for each participant and thus the mean differences will be slightly different than the differences between the group means.